Siegfried Holding AG
SFZN: XSWX (CHE)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| #DQ | LOCK|sdh$^ | LOCK|$F^RPv |
Siegfried Earnings: Impressive Profit Margins in 2025, but Soft 2026 Guidance Triggers Selloff
Siegfried delivered 2025 revenue of CHF 1.33 billion, up 2.6% from the prior year, and a core EBITDA margin of 23.5%. Management is guiding to low-single-digit sales growth in 2026, driven by low-single-digit growth in the drug substances division. Shares declined nearly 9% on Feb. 20.
